P.S. Singh et al.
Journal of Photochemistry & Photobiology, A: Chemistry 419 (2021) 113457
2
7
.3.1.1. 2,3-bis(4-(9H-carbazol-9-yl)phenyl)naphtho[2,3–f]quinoxaline-
,12-dione (2). Similar procedure adopted as for 1 using, 2,3-bis(4-
184.07 (ꢀ C = O), 149.04, 147.59, 146.88, 141.10, 140.62, 136.08,
131.75, 126.52, 123.63, 122.17, 120.98, 120.55, 120.29, 109.99,
+
bromophenyl)-naphtho[2,3–f]quinoxaline-7,12-dione (200 mg, 0.35
mmol) an aryl halide precursor, 9H-carbazole amine (117 mg, 0.7
108.05, MALDI-TOF: mass calcd. for C52
H
28
4
N O
2
[M ]: 740.80; found
+
[M ]: 740.82, elemental anal. calcd. for C52
H
28
N
4
O
2
: C, 84.31; H, 3.81;
mmol), palladium catalyst [Pd
2
(dba)
3
] (25 mg), 2-dicyclohexylphosh-
N, 7.56%; found: C, 84.37; H, 3.73; N, 7.60 %.
pino-20,60-dimethylbiphenyl (SPhos) (25 mg) as co-ligand and
sodium-t-butoxide (90 mg) a base were added to the reaction mixture.
Eluent:- n-hexane:chloroform: 10:90, orange solid, yield 0.158 g
2.3.1.5. 2-(9H-carbazol-9-yl)-5-ethyl-5H-benzo[g]indolo[2,3–b]quinoxa-
line (6). Similar procedure adopted as for 1 starting from, 2-bromo-5-
ethyl-5H-Benz[g]indolo[2,3–b]quinoxaline (200 mg, 0.6 mmol) an aryl
halide precursor, 9H-carbazole amine (100 mg, 0.6 mmol), palladium
catalyst [Pd (dba) ] (15 mg), 2-dicyclohexylphoshpino-20,60-dimethyl-
◦
ꢀ 1
(
61%), mp > 250 C, FTIR (solid,
ν
max/cm ): 3057, 2935 (Ar. = C–H
str.), 1667 (ꢀ C = O), 1595, 1448 (Ar.–C = C str.), 1339 (C–N str.), 1216,
1
7
25 (Ar.–C–H bend), H NMR could not be obtained because of very
2
3
13
◦
poor solubility, C NMR (solid, 125 MHz, 25 C) δ(ppm): 180.35 (ꢀ C =
O), 179.69 (ꢀ C = O), 150.16, 149.11, 147.72, 146.38, 133.17, 132.28,
biphenyl (SPhos) (15 mg) as co-ligand and sodium-t-butoxide (60 mg) a
base were added to the reaction mixture.
1
1
28.20, 126.33, 124.94, 119.76, 117.87, 116.64, 116.02, 106.27,
Eluent:- n-hexane:chloroform :: 45:55, orange solid, yield 0.156 g
+
ꢀ 1
◦
04.21, MALDI-TOF: mass calcd. for C52
H
30
N
4
O
2
[M ]: 742.82; found
(64%), mp 230 C, FTIR (solid,
ν
max/cm ): 3055, 2975, (Ar. = C–H
+
[
M ]: 742.93, elemental anal. calcd. for C52
H
30
N
4
O
2
: C, 84.08; H, 4.07;
str.), 2866 (Aliph.–C–H str.), 1598, 1448 (Ar.–C = C str.), 1336 (C–N
1
◦
N, 7.54%; found: C, 83.98; H, 4.01; N, 7.72%.
str.), 1121, 875, 738 (Ar.–C–H bend), H NMR (CDCl , 300 MHz, 25 C)
3
δ (ppm): 8.84 (1H, s, ArH), 8.63–8.56 (2H, m, ArH), 8.16–8.07 (3H, m,
2
.3.1.2. 3,6-di(9H-carbazol-9-yl)tribenzo[a,c,i]phenazine
(3). Similar
ArH), 7.78–7.25 (12H, m, ArH (1H extra due to residual CHCl
3
in
procedure adopted as for 1 starting from, 3,6-dibromotribenzo[a,c,i]
phenazine (200 mg, 0.4 mmol) an aryl halide precursor, 9H-carbazole
CDCl
3
)), 4.49 (2H, q, N–CH
7.2 Hz); C NMR (CDCl
2
, J = 7.2, 7.2 Hz), 1.52 (3H, t, ꢀ CH
3
, J = 7.2,
1
3
◦
3
, 75 MHz, 25 C) δ (ppm): 145.74, 143.86,
amine (133 mg, 0.8 mmol), palladium catalyst [Pd
2
(dba)
3
] (20 mg), 2-
141.58, 137.86, 137.32, 134.23, 133.64, 131.53, 131.43, 128.47,
127.89, 127.76, 126.95, 126.47, 125.91, 125.26, 124.79, 121.41,
dicyclohexylphoshpino-20,60-dimethylbiphenyl (SPhos) (20 mg) as co-
ligand and sodium-t-butoxide (80 mg) a base were added to the reaction
mixture.
120.36, 113.72, 110.66, 109.72, 36.25 (N–CH
2
), 13.44 (ꢀ CH
3
)),
+
+
MALDI-TOF: mass calcd. for C32
H
22
N
4
[M ]: 462.54; found [M ]:
Eluent:- n-hexane:chloroform :: 20:80, orange solid, yield 0.124 g
462.65, elemental anal. calcd. for C32
22 4
H N : C, 83.09; H, 4.79; N,
◦
ꢀ 1
(
46%), mp > 250 C, FTIR (solid,
ν
max/cm ): 3044, 2921, 2825(Ar. =
12.11%; found: C, 83.12; H, 4.70; N, 12.18%.
C–H str.), 1598, 1448 (Ar.–C = C str.), 1338 (C–N str.), 1216, 725 (Ar.–
1
C–H bend), H NMR could not be obtained because of very poor solu-
2.3.1.6. 2-(9H-carbazol-9-yl)-6-methyl-6H-indolo[2,3–b]quinoxaline
(7). Similar procedure adopted as for 1 starting from, 2-bromo-6-
methyl-6H-indolo[2,3–b]quinoxaline (200 mg, 0.64 mmol) an aryl
halide precursor, 9H-carbazole amine (107 mg, 0.64 mmol), palladium
catalyst [Pd (dba) ] (15 mg), 2-dicyclohexylphoshpino-20,60-dimethyl-
bility, 13C NMR (solid, 125 MHz, 25 C) δ (ppm): 133.37, 128.85,
◦
1
27.20, 119.17, 116.32, 103.02. MALDI-TOF: mass calcd. for C48
H
28
N
4
+
+
[
M ]: 660.76; found [M ]: 660.91, elemental anal. calcd. for C48
H
28
N
4
:
C, 87.25; H, 4.27; N, 8.48%; found: C, 87.16; H, 4.32; N, 8.53%.
2
3
biphenyl (SPhos) (15 mg) as co-ligand and sodium-t-butoxide (65 mg) a
base were added to the reaction mixture.
2
.3.1.3. 3,6,11-tri(9H-carbazol-9-yl)dibenzo[a,c]phenazine (4). Similar
procedure adopted as for 1 starting from, 3,6,11-tribromodibenzo[a,c]
phenazine (200 mg, 0.4 mmol) an aryl halide precursor, 9H-carbazole
Eluent:- n-hexane:chloroform :: 60:40, yellow green solid, yield
◦
ꢀ 1
0.132 g (52%), mp 210 C, FTIR (solid,
ν
max/cm ): 3057, 2921 (Ar. =
amine (198 mg, 1.2 mmol), palladium catalyst [Pd
2
(dba)
3
] (25 mg), 2-
C–H str.), 2839 (Aliph.–C–H str.), 1598, 1448 (Ar.–C = C str.), 1332
1
◦
3
, 300 MHz, 25 C)
dicyclohexylphoshpino-20,60-dimethylbiphenyl (SPhos) (25 mg) as co-
ligand and sodium-t-butoxide (110 mg) a base were added to the reac-
tion mixture.
(C–N str.), 1118, 752 (Ar.–C–H bend), H NMR (CDCl
δ (ppm): 8.52–8.44 (2H, m, ArH), 8.33–8.30 (1H, m, ArH), 8.18–8.15
(2H, m, ArH), 7.98–7.94 (1H, m, ArH), 7.71–7.56 (3H, m, ArH),
Eluent:- n-hexane:chloroform :: 5:95, orange solid, yield 0.134 g
7.47–7.29 (7H, m, ArH, (1H extra due to residual CHCl
3 3
in CDCl )), 3.98
◦
ꢀ 1
13
◦
(
45%), mp > 250 C, FTIR (solid,
ν
max/cm ): 3071, 2921 (Ar. = C–H
(3H, s, N–CH
3
), C NMR (CDCl
3
, 75 MHz, 25 C) δ (ppm): 145.16,
str.), 1609, 1462 (Ar.–C = C str.), 1339 (C–N str.), 1216, 738 (Ar.–C–H
140.86, 135.19, 131.39, 129.11, 127.86, 126.46, 126.07, 123.58,
1
bend), H NMR could not be obtained because of very poor solubility,
122.88, 121.18, 120.33, 120.24, 109.95, 109.86, 109.30, 29.69
1
3
◦
+
C NMR (solid, 125 MHz, 25 C) δ (ppm): 139.75, 138.57, 135.07,
34.18, 133.94, 126.02, 121.91, 119.09, 115.95, 107.90, 103.83,
(N–CH
3
), MALDI-TOF: mass calcd. for C27
H
18
N
4
[M ]: 398.46; found
: C, 81.39; H, 4.55; N,
+
1
1
[M ]: 398.96, elemental anal. calcd. for C27
H
18
N
4
+
03.39, 102.71, MALDI-TOF: mass calcd. for C56
H
33
N
5
[M ]: 775.89;
14.06%; found: C, 81.46; H, 4.45; N, 14.10%.
+
found [M ]: 775.47, elemental anal. calcd. for C56
H
33
5
N : C, 86.69; H,
′
′
4
.29; N, 9.03%; found: C, 86.61; H, 4.40; N, 8.98%.
2.3.1.7. 3-(9H-carbazol-9-yl)-10-methyl-10H-pyrido[3 ,2 :5,6]pyrazino
2,3–b]indole (8). Similar procedure adopted as for 1 starting from, 3-
[
′
′
2
8
.3.1.4. 2,17-di(9H-carbazol-9-yl)dibenzo[a,c]naphtho[2,3–h]phenazine-
,13-dione (5). Similar procedure adopted as for 1 starting from, 2,17-
bromo-10-methyl-10H-pyrido[3 ,2 :5,6]pyrazino[2,3–b]indole
mg, 0.64 mmol) an aryl halide precursor, 9H-carbazole amine (107 mg,
0.64 mmol), palladium catalyst [Pd (dba) ] (15 mg), 2-dicyclohexyl-
(200
dibromodibenzo[a,c]naphtho[2,3–h]phenazine-8,13-dione (200 mg,
.35 mmol) an aryl halide precursor, 9H-carbazole amine (117 mg, 0.7
mmol), palladium catalyst [Pd (dba) ] (20 mg), 2-dicyclohexylphosh-
2
3
0
phoshpino-20,60-dimethylbiphenyl (SPhos) (15 mg) as co-ligand and
sodium-t-butoxide (60 mg) a base were added to the reaction mixture.
Eluent:- n-hexane:chloroform :: 35:65, Yellow solid, yield 0.142 g
2
3
pino-20,60-dimethylbiphenyl (SPhos) (20 mg) as co-ligand and
sodium-t-butoxide (85 mg) a base were added to the reaction mixture.
Eluent:- n-hexane:chloroform :: 25:75, red solid, yield 0.112 g (43%),
◦
ꢀ 1
(56%), mp 218 C, FTIR (solid,
ν
max/cm ): 3044, 2907 (Ar. = C–H str.),
2839 (Aliph.–C–H str.), 1598, 1475 (Ar.–C = C str.), 1393 (C–N str.),
◦
ꢀ 1
1
◦
3
, 300 MHz, 25 C)
mp 242 C, FTIR (solid,
ν
max/cm ): 3057, 2907, 2839 (Ar. = C–H str.),
1254, 1134, 738, 466 (Ar.–C–H bend), H NMR (CDCl
1
669 (ꢀ C = O), 1570, 1448 (Ar.–C = C str.), 1336 (C–N str.), 1257, 708
δ(ppm): 9.41 (1H, s, ArH), 8.88–8.51 (2H, m, ArH), 8.21–8.18 (2H, m,
1
◦
(
Ar.–C–H bend), H NMR (CDCl
3
, 300 MHz, 25 C) δ (ppm): 9.78 (1H, d,
ArH), 7.81–7.26 (10H, m, ArH (1H extra due to residual CHCl
3
in
1
3
◦
ArH, J = 9.0 Hz), 9.57 (1H, d, ArH J = 9.0 Hz), 9.05–8.93 (m, 2H, ArH),
CDCl
3
)), 4.10 (3H, s, N–CH
3 3
), C NMR (CDCl
, 75 MHz, 25 C) δ (ppm):
8
.36–8.02 (18H, m, ArH), 7.73–7.56 (6H, m, ArH), 7.25 (1H due to
152.70, 151.48, 150.85, 148.27, 141.64, 140.34, 132.43, 128.01,
126.08, 123.86, 123.30, 122.30, 121.02, 120.09, 109.68, 101.76, 27.93
1
3
◦
residual CHCl
3
in CDCl
3
), C NMR (CDCl
3
, 75 MHz, 25 C) δ (ppm):
4